Rosa F. Yeh

905 total citations
25 papers, 682 citations indexed

About

Rosa F. Yeh is a scholar working on Infectious Diseases, Hematology and Oncology. According to data from OpenAlex, Rosa F. Yeh has authored 25 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 7 papers in Hematology and 5 papers in Oncology. Recurrent topics in Rosa F. Yeh's work include HIV/AIDS drug development and treatment (9 papers), HIV/AIDS Research and Interventions (6 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Rosa F. Yeh is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV/AIDS Research and Interventions (6 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Rosa F. Yeh collaborates with scholars based in United States, Canada and Netherlands. Rosa F. Yeh's co-authors include Naser L. Rezk, Angela D. M. Kashuba, Kristine B. Patterson, Julie B. Dumond, John Rublein, Myron S. Cohen, Byung Hwa Jung, Paul W. Stewart, Cheri E. Klein and Amanda Corbett and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Rosa F. Yeh

23 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosa F. Yeh United States	12	348	166	140	135	105	25	682
J Biollaz Switzerland	14	263 0.8×	130 0.8×	114 0.8×	157 1.2×	94 0.9×	16	769
Aurélie Fayet Switzerland	9	408 1.2×	254 1.5×	86 0.6×	58 0.4×	111 1.1×	11	552
Marie‐Claude Gagnieu France	19	278 0.8×	71 0.4×	145 1.0×	273 2.0×	102 1.0×	63	889
Hawazin Faruki United States	18	168 0.5×	100 0.6×	87 0.6×	254 1.9×	88 0.8×	29	908
Natsuo Tachikawa Japan	16	533 1.5×	217 1.3×	240 1.7×	284 2.1×	66 0.6×	74	999
Gregory E. Chittick United States	15	484 1.4×	287 1.7×	127 0.9×	198 1.5×	116 1.1×	18	798
Mary Beth Wire United States	18	325 0.9×	170 1.0×	186 1.3×	289 2.1×	144 1.4×	36	957
Daniel Röshammar Sweden	12	264 0.8×	149 0.9×	78 0.6×	77 0.6×	72 0.7×	22	564
Odin Naderer United States	12	287 0.8×	109 0.7×	92 0.7×	217 1.6×	69 0.7×	32	729
Lillian Ting Canada	15	537 1.5×	303 1.8×	54 0.4×	273 2.0×	114 1.1×	26	1.1k

Countries citing papers authored by Rosa F. Yeh

Since Specialization

Citations

This map shows the geographic impact of Rosa F. Yeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa F. Yeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa F. Yeh more than expected).

Fields of papers citing papers by Rosa F. Yeh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa F. Yeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa F. Yeh. The network helps show where Rosa F. Yeh may publish in the future.

Co-authorship network of co-authors of Rosa F. Yeh

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa F. Yeh. A scholar is included among the top collaborators of Rosa F. Yeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa F. Yeh. Rosa F. Yeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lindsay, Julian, Elizabeth M. Krantz, Frank Tverdek, et al.. (2025). P-1750. Assessment of Antimicrobial Stewardship Guided CYP2C19 Pharmacogenomic Voriconazole Dosing: Practicalities and Impact on Clinical Management. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations

Lindsay, Julian, Elizabeth M. Krantz, Jessica Morris, et al.. (2022). Voriconazole in Hematopoietic Stem Cell Transplantation and Cellular Therapies: Real-World Usage and Therapeutic Level Attainment at a Major Transplantation Center. Transplantation and Cellular Therapy. 28(8). 511.e1–511.e10. 10 indexed citations

McCune, Jeannine S., Arjen M. Punt, Rosa F. Yeh, et al.. (2021). Quality Control of Busulfan Plasma Quantitation, Modeling, and Dosing: An Interlaboratory Proficiency Testing Program. Therapeutic Drug Monitoring. 43(5). 657–663. 7 indexed citations

Khandelwal, Pooja, Rosa F. Yeh, Adam Lane, et al.. (2020). Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and Thiotepa. Transplantation. 105(4). 891–896. 17 indexed citations

Nance, Christina, Rosa F. Yeh, Mary E. Paul, et al.. (2017). Translational Medicine in HIV-1 Infection: Preclinical and Clinical Development of the Green Tea Catechin, Epigallocatechin Gallate, as Therapy and Immunological Signatures. Journal of Allergy and Clinical Immunology. 139(2). AB209–AB209. 1 indexed citations

Rodler, Eve T., Brenda F. Kurland, Melissa Griffin, et al.. (2016). Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation–Associated Breast Cancer. Clinical Cancer Research. 22(12). 2855–2864. 69 indexed citations

Freytes, César O., Juan J. Toro, Rosa F. Yeh, et al.. (2014). Safety and Efficacy of Targeted-Dose Busulfan and Bortezomib as a Conditioning Regimen for Patients with Relapsed Multiple Myeloma Undergoing a Second Autologous Blood Progenitor Cell Transplantation. Biology of Blood and Marrow Transplantation. 20(12). 1949–1957. 4 indexed citations

Kassim, Adetola A., Rosa F. Yeh, Jennifer Domm, et al.. (2013). Targeted Busulfan therapy with a steady-state concentration of 600–700 ng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant. Bone Marrow Transplantation. 49(3). 366–369. 21 indexed citations

Yeh, Rosa F., et al.. (2012). The association of pharmacy drug-delivery services with adherence in an urban HIV population†. Journal of Pharmaceutical Health Services Research. 3(4). 185–190.

10.

Yeh, Rosa F., David K. Blough, George B. McDonald, et al.. (2011). Accurate Targeting of Daily Intravenous Busulfan with 8-Hour Blood Sampling in Hospitalized Adult Hematopoietic Cell Transplant Recipients. Biology of Blood and Marrow Transplantation. 18(2). 265–272. 50 indexed citations

11.

Birtcher, Kim K., et al.. (2010). Symposium on roles of and cooperation between academic- and practice-based pharmacy clinicians. American Journal of Health-System Pharmacy. 67(3). 231–238. 5 indexed citations

12.

Palmer, Hannah R., Jessica Cottreau, Kevin W. Garey, et al.. (2010). Significant publications on infectious diseases pharmacotherapy in 2009. American Journal of Health-System Pharmacy. 67(15). e34–e42. 14 indexed citations

13.

Yeh, Rosa F., Rupali Jain, & Hannah R. Palmer. (2009). 49th ICAAC Annual Meeting: optimization of anti-infective use in the clinical setting. Expert Review of Anti-infective Therapy. 7(10). 1167–1172. 4 indexed citations

14.

Yeh, Rosa F., Naser L. Rezk, Angela D. M. Kashuba, et al.. (2009). Genital Tract, Cord Blood, and Amniotic Fluid Exposures of Seven Antiretroviral Drugs during and after Pregnancy in Human Immunodeficiency Virus Type 1-Infected Women. Antimicrobial Agents and Chemotherapy. 53(6). 2367–2374. 50 indexed citations

15.

Sansgiry, Sujit S., et al.. (2008). Impact of Over-the-Counter Medication Misuse and Adverse Drug Events on HIV Patients' Health-Related Quality of Life. Journal of Pharmacy Technology. 24(6). 323–329. 2 indexed citations

16.

Sansgiry, Sujit S., et al.. (2008). Use/misuse of over-the-counter medications and associated adverse drug events among HIV-infected patients. Research in Social and Administrative Pharmacy. 4(3). 292–301. 12 indexed citations

17.

Yeh, Rosa F., Kristi Kuper, Elizabeth A. Coyle, et al.. (2008). Significant publications on infectious diseases pharmacotherapy in 2007. American Journal of Health-System Pharmacy. 65(22). e72–e79. 9 indexed citations

18.

Dumond, Julie B., Rosa F. Yeh, Kristine B. Patterson, et al.. (2007). Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis. AIDS. 21(14). 1899–1907. 158 indexed citations

19.

Yeh, Rosa F., Kristine B. Patterson, Naser L. Rezk, et al.. (2006). Lopinavir/Ritonavir Induces the Hepatic Activity of Cytochrome P450 Enzymes CYP2C9, CYP2C19, and CYP1A2 But Inhibits the Hepatic and Intestinal Activity of CYP3A as Measured by a Phenotyping Drug Cocktail in Healthy Volunteers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 42(1). 52–60. 159 indexed citations

20.

Rezk, Naser L., Rustin D. Crutchley, Rosa F. Yeh, & Angela D. M. Kashuba. (2006). Full Validation of an Analytical Method for the HIV-Protease Inhibitor Atazanavir in Combination With 8 Other Antiretroviral Agents and its Applicability to Therapeutic Drug Monitoring. Therapeutic Drug Monitoring. 28(4). 517–525. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact